CCCC Earnings

Quarterly EPS
$-0.49
Q4 2024
$-0.37
Q1 2025
$-0.37
Q2 2025
$-0.44
Q3 2025
$-0.17
Q4 2025
$-0.20
Q1 2026
$-0.18
Q2 2026
$-0.16
Q3 2026
Latest Revenue8.5M
Latest Net Income-21843000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.168.5M-21843000-24.6%+63.6%
Q2 2026-$0.186.6M-23635000+2.8%+51.4%
Q1 2026-$0.206.2M-25129000-15.0%+45.9%
Q4 2025-$0.1711.0M-20486000+112.8%+65.3%
Q3 2025-$0.4411.2M-32166000-26.9%-25.7%
Q2 2025-$0.376.5M-26020000-46.2%-42.3%
Q1 2025-$0.377.2M-26322000+138.2%+9.8%
Q4 2024-$0.495.2M-34573000+58.8%+27.9%
Q3 2024-$0.3515.4M-24666000——
Q2 2024-$0.2612.0M-17716000——
Q1 2024-$0.413.0M-28361000——
Q4 2023-$0.683.3M-34754000——
C4 Therapeutics (CCCC) — Earnings